Summary
Thyronine (T4), triiodothyronine (T3), and reversetriiodothyronine (rT3) levels were evaluated in cerebrospinal fluid (CSF) and in serum of 12 patients with definite amyotrophic lateral sclerosis (ALS) by specific radioimmunoassays. Circulating microsomal and thyroglobulin antibodies were also evaluated. In all patients serum levels of T4, T3 and rT3 were within normal limits. In CSF, the rT3 levels were significantly elevated to 0.118 μg/l (mean), the T4 levels were not significantly elevated, and the T3 levels were below the detection limit of 0.03 μg/l. A correlation between the elevated rT3 levels in CSF and the severity or type of ALS could not be demonstrated by this study. The antithyroid antibodies (thyroglobulin antibodies, microsomal antibodies) showed normal titres and did not suggest disturbances of thyroid autoimmunity in the patients with ALS.
Article PDF
Avoid common mistakes on your manuscript.
References
Antel JP, Noronha A, Oder J (1982) Immunology of amyotrophic lateral sclerosis. In: Rowland LP (ed) Human motor neuron diseases. Raven Press, New York, pp 395–401
Appel StH, Stockton-Appel V, Stewart S, Kerman RH (1986) Amyotrophic lateral sclerosis. Associated clinical disorders and immunological evaluations. Arch Neurol 43:234–238
Engel WK, Siddeque T, Nicoloff JT (1983) Effect on weakness and spasticity in ALS of thyrotropin releasing hormone. Lancet I:73–74
Fuhrmann H, Ködding R, Schliack H, Mühlen A von zur (1980) Jodthyronine im Liquor cerebrospinalis bei multipler Sklerose und 3 Vergleichskollektiven. Akt Neurol 7:103–107
Hagen GA, Solberg LA Jr (1974) Brain and cerebrospinal fluid permeability to intravenous thyroid hormones. Endocrinology 95:1398–1410
Jackson IM, Adelman LS, Munsat TL, Forte S (1986) Amyotrophic lateral sclerosis: thyrotropin-releasing hormone and histidyl proline diketopiperazine in the spinal cord and cerebrospinal fluid. Neurology 36:1218–1223
Kaplan MM, Taft JA, Reichlin S, Munsat TL (1986) Sustained rises in serum thyrotropin, thyroxine, and triiodothyronine during long term, continuous thyrotropin-releasing hormone treatment in patients with amyotrophic lateral sclerosis. J Clin Endocrinol Metab 63:808–814
Kiessling WR (1982) Thyroid function in 44 patients with amyotrophic lateral sclerosis. Arch Neurol 39:241–242
Ködding R, Hesch RD, Mühlen A von zur (1976) A radioimmunoassay for reverse triiodothyronine. Acta Endocrinol (Copenh) [Suppl] 202:47–49
Ködding R, Janzen J, Schmidt E, Hesch RD (1976) Reverse triiodothyronine in liver disease. Lancet II:314
Mager J (1976) Myatrophe Lateralsklerose: Zwei ungewöhnliche Verläufe. Nervenarzt 47:261–264
Malin JP, Haas J, Kalies I (1986) Azetylcholin-Rezeptoren-Antikörper bei amyotropher Lateralsklerose (ALS). Joint Meeting of the German Neurological Society and the Neurological Societies of the Benelux-Countries. Aachen, 17–20 September 1986
McMenamin J, Coxson M (1980) Motor neuron disease and hyperthyroid Graves disease: a chance association? J Neurol Neurosurg Psychiatry 43:46–49
Mitsumoto H, Salgado ED, Negroski D, Hanson MR (1986) Amyotrophic lateral sclerosis: effects of acute intravenous and chronic subcutaneous administration of thyrotropin-releasing hormone in controlled trials. Neurology 36:152–159
Mora JS, Munsat TL, Kao KP, Finison LJ (1986) Intrathecal administration of natural human interferon alpha in amyotrophic lateral sclerosis. Neurology 36:1137–1140
Nishikawa M, Inada M, Naito K (1982) 3,3′,5′-Triiodothyronine (reverse T3) in human cerebrospinal fluid. J Clin Endocrinol Metab 53:1030–1035
Thompson P, Burman KD, Wright FD (1982) Iodothyronine levels in human cerebrospinal fluid. J Clin Endocrinol Metab 54:653–655
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Malin, JP., Ködding, R., Fuhrmann, H. et al. T4, T3 and rT3 levels in serum and cerebrospinal fluid of patients with amyotrophic lateral sclerosis. J Neurol 236, 57–59 (1989). https://doi.org/10.1007/BF00314221
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00314221